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Background: The mechanisms of neointima formation after synthetic vascular grafting are not clear. The aim of this study
was to investigate the intima and perigraft adventitia remodeling process in terms of cell apoptosis versus proliferation
after synthetic patch implantation.
Methods: Female Merino sheep were randomized equally into two groups and underwent implantion with a patch of
gelatin sealed Dacron graft into the left common carotid artery. At 1 and 6 months, grafted vessels were harvested,
processed, and assessed. Intimal area and lumen sizes were measured with histologic assessment of eight segments from
each animal assisted with image analysis. Immunohistochemical labeling of -actin and D33 desmin was performed on
tissue sections of perigraft adventitia, graft matrix, and intima. Cell proliferation and cell phenotype were determined
with double immunohistochemical staining with anti–proliferating cell nuclear antigen and anti–-actin or antimacro-
phage antibodies (HAM 56) in perigraft adventitia, graft matrix, and intima. Apoptosis was detected with in situ terminal
deoxynucleiotidyl transferase–mediated 2-deoxyuridine 5-triphosphate–fluorescence nick end labeling (TUNEL) in
perigraft adventitia, graft matrix, and intima.
Results: The carotid artery lumen size at 6 months was significantly larger than at 1 month (P< .05). The intimal area was
significantly reduced at 6 months compared with 1 month (P < .05). At 1 month and 6 months, perigraft adventitia, graft
matrix, and intima showed positive -actin expression but negative desmin staining. In the anastomotic area, a small
number of intimal cells suggested their muscle origin (expression -actin and desmin). The number of proliferating cells
in the intima was significantly greater at 1 month than at 6 months (P  .01). TUNEL-positive cells were significantly
greater in the intima at 1 month than at 6 months (P < .05), whereas TUNEL-positive cells were significantly greater at
6 months in the perigraft adventitia (P < .05). HAM 56–positive cells in the intima at 1 month were significantly greater
compared with 6 months (P < .05), whereas in graft and perigraft regions, no significant difference was seen between 1
month and 6 months.
Conclusion: The cell proliferation and cell phenotype change in intima and perigraft adventitia are associated with
thickening of perigraft adventitia and intima at 1 month. The balance between cell proliferation and apoptosis could
account in part for the reduction in intima area and perigraft adventitial cellularity at 6 months. (J Vasc Surg 2002;36:
371-8.)
Neointima formation is one of the main features after
vascular interventions, such as balloon angioplasty, stent-
ing, and vascular grafting. Synthetic vascular patch implan-
tation is a common surgical procedure. The placement of a
synthetic graft necessitates the formation of a surgical anas-
tomotic wound and leaves a foreign porous material ex-
posed in the circulation. The adventitia has been consid-
ered a site of perigraft inflammation, although cell
infiltration also has been shown in histologic studies.1
Adventitial myofibroblasts have been identified in ad-
ventitia and intima in a porcine model of balloon over-
stretch coronary artery injury and have been shown to
contribute to neointima formation after saphenous vein
bypass grafts.2,3 The adventitial change, such as hypercel-
lularity of the adventitial layer, proliferation of fibroblasts,
and modulation of their phenotype to myofibroblasts are
associated with the adventitial remodeling after coronary
angioplasty.4 The role of perigraft adventitial change has
not been addressed in prior studies of vascular response to
synthetic vascular implantation.
Great emphasis has been placed on cell proliferation in
neointima formation. However, the balance between cell
growth and programmed cell death (apoptosis) determines
the extent of the resulting neointima formation. Apoptosis
occurs in a wide range of pathologic and normal tissues. In
the cardiovascular system, apoptosis has been reported in
conditions such as atherosclerosis, organ development. and
hypertension,5-8 which supports our hypothesis that apop-
tosis along with cellular proliferation contributes to neoin-
timal formation after synthetic vascular patch implantation.
The aims of this study were to show cell phenotypic change
in intima and perigraft adventitia and to investigate the role
of cell proliferation and apoptosis in intima and perigraft
adventitia remodeling.
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These studies were performed after approval from the
Animal Care and Ethics Committee of Westmead Hospital
with conditions consistent with the research guidelines of
the Australian National Health and Medical Research
Council.
Surgery. Twenty adult female Merino sheep (weight,
35 to 45 kg) received a gelatin sealed Dacron patch graft
(Gelsoft, Sulzer Vascutek Ltd, Glasgow, Scotland) im-
planted into the left common carotid artery. One sheep
died after surgery. Nine sheep were killed at 1 month, and
the remaining 10 sheep were killed at 6 months. The
surgical procedures were performed as previously de-
scribed.9 In brief, general anesthesia was induced with
intravenous thiopentone (16 mg/kg; Abbott Australia Pty
Ltd, Sydney, New South Wales, Australia) and maintained
with 1% to 2% halothane (Zeneca Ltd, Macclesfield, United
Kingdom) in oxygen inhalation after intubation. The left
common carotid artery was exposed via a longitudinal
incision in the neck. Before clamping of the artery, 5000 IU
of heparin (David Bull Laboratories, Sydney, New South
Wales, Australia) was given intravenously. A patch of gela-
tin sealed Dacron graft was trimmed into a fusiform shape
and sutured into the artery.
Histologic preparation and morphometry. At the
specified time points, with a further general anesthetic, a
cannula was inserted into the left common carotid artery
proximal to the patch and perfused with 10% buffered
formalin at 100 mm Hg for 10 to 15 minutes. The sheep
were killed with intravenous thiopentone, and the graft was
harvested together with adjacent artery and immersed into
10% buffered formalin for at least 24 hours. The vessels
then were cut into eight transverse segments at equidistant
intervals along the graft; four of these were embedded in
one paraffin block, and the other four segments in a second
paraffin block. Two paraffin blocks were derived from each
harvested carotid artery, and each block was composed of
four segments.
Sections of 5-m thickness were cut from each block
and stained with hematoxylin and eosin for morphometric
analysis. Slides were coded to allow assessment without
knowledge of origin. A digital image of cross sections from
each segment was captured with Pulnix (TMC 6) color
video camera (Pulnix America Inc, Sunnyvale, Calif). The
area of intima (area between lumen and graft) and the
lumen size (the area circumscribed by the intima border)
on each segment on the section were measured with com-
puter-assisted morphometry aided with computer image
analysis software Optimas (Optimas Corporation, Seattle,
Wash). One section from each of the two paraffin blocks
was attained for analysis. So, in total, two paraffin sections
containing eight segments of each vessel were examined to
derive the average intima area and lumen size. Comparisons
were made between animals killed at 1 month and at 6
months.
Identification of infiltrating cell phenotypes. For
cell-type identification, Dako Envision Doublestain System
(Dako Corporation, Carpinteria, Calif) was used. Mono-
clonal mouse anti–-smooth muscle actin (clone 1A4; Im-
munotech, Marseille, France) and monoclonal mouse anti-
human antibody (clone D33; Dako Corporation) were
used as the primary antibodies. 1A4 recognizes -actin in
smooth muscle, myoepithelial cells, pericytes, and myofi-
broblasts. D33 monoclonal antibody reacts with the 53-
kDa intermediate filament protein desmin in muscle cells.
After deparaffinizing, slides were immersed in Dako target
retrieval solution and irradiated in a microwave for 10
minutes. The primary antibodies were applied on serial
tissue sections respectively, followed by application of alka-
line phosphatase–labeled polymer. Fast Red solution was
used as chromogen and counterstained with Mayer’s hema-
toxylin (Sigma Diagnostic, St Louis, Mo). -Actin–positive
and desmin-positive cells stained as blue nuclei (hematox-
ylin) surrounded by red stained cytoplasm on the serial
section. Negative control was also performed with staining
without primary antibody.
Assessment of proliferating cells and phenotypes.
For identification of the proliferating cells and their cellular
phenotype, a Dako Envision Doublestain System was used.
After similar deparaffinization and microwave antigen re-
trieval, tissue sections were incubated with a PC10 mono-
clonal mouse anti–proliferating cell nuclear antigen
(PCNA) antibody (Dako Corporation) followed by incu-
bation with horseradish peroxidase–labeled polymer. Liq-
uid diaminobenzidine conjugated peroxidase was used as
the chromogen. After PCNA staining was completed, dou-
blestain block was applied. The slides then were stained
with either HAM 56 antimacrophage monoclonal mouse
antibody (Dako Corporation) or with 1A4 monoclonal
mouse anti–-actin antibody, followed by alkaline phos-
phatase–labeled polymer and color development with Fast
Red solution. The sections were counterstained with May-
er’s hematoxylin. Proliferating macrophages or -actin–
positive cells were evident with red-brown colored nuclei
surrounded by red colored stained HAM 56 or -actin
cytoplasm. Negative controls also were performed with
staining carotid sections without primary or secondary an-
tibodies.
The numbers of -actin–positive, HAM 56–positive,
and PCNA-positive cells also were counted in three regions
as graft region, within the graft matrix; intima region; and
perigraft region, the perigraft adventitia adjacent to the
graft. Individual cells were counted with the presence of
well-defined cell nuclei. Each segment of the tissue section
was analyzed with the microscope (400 magnification),
10 fields were randomly selected from each region, and a
microscopic field was captured with the digital camera. The
cells of interest were counted, aided with the same com-
puter image analysis software. A mean value per region of
each vessel was obtained with averaging values from eight
sections from two blocks. The data are presented as mean
standard deviation. A t test for independent sample was
performed, and correlation coefficients values were deter-
mined. Values of P less than .05 were considered signifi-
cant.
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Detection of apoptosis. Apoptosis was detected in
situ on carotid artery cross sections with terminal deoxynu-
cleotidyl transferase (TdT)–mediated fluorescent labeling
(TUNEL) with the In Situ Cell Death Detection Kit
(Boehringer Mannheim Corp, Indianapolis, Ind).10 Cross
sections were dewaxed, rehydrated, and immersed in ad-
justed extreme acidic antigen retrieval solution (pH, 3;
Dako Corporation). Sections were irradiated for 10 min-
utes, followed by incubation with 20 g/mL proteinase K
(Boehringer Mannheim, GmbH, Germany) before block-
ing. Sections were incubated with TUNEL mixture (TdT
and fluorescently labeled 2-deoxyuridine 5-triphosphate
in a TdT buffer), followed by incubation with converter-
peroxidase antibody. Fluorescent labeled fragmented DNA
was detected with liquid diaminobenzidine-conjugated per-
oxidase. Sections were counterstained with Mayer’s hematox-
ylin and mounted with Aqueous Permanent Ultramounting
media (Dako Corporation). Cells with a brown-red nuclear
labeling were defined as TUNEL positive. Mouse small
intestine was used as positive control for detection of
apoptotic cells. In negative control experiments, TdT was
omitted from the labeling mixture, and no staining was
detected.
For TUNEL staining, a semiquantitative assessment to
grade positive TUNEL staining was used. The cell count
was performed with the 400 magnification microscope;
ten fields from each section were randomly selected. Scor-
ing of TUNEL-positive cells was as follows: 0, no visible
staining; 1, less than 10 visible cells staining; 2, 10 to 50
visible cells staining; 3, 50 to 100 visible cells; and 4, more
than 100 visible cells. The data were presented as mean rank
and sum of ranks, and two-tailed P value was obtained. The
TUNEL scores were compared with the Mann-Whitney U
and Wilcoxon rank sum W tests. Values of P less than .05
were considered significant.
RESULTS
Morphology and morphometry. For both the
1-month and 6-month groups, all vessels were patent and
no thrombus was seen in any of the harvested carotid
arteries. All carotid arteries developed neointima at 1
month and 6 months. Although measurement of the peri-
graft adventitia area is difficult, the histologic sections
clearly showed less staining of nuclei at 6 months compared
with 1 month. The perigraft adventitia layer at 6 months
was thinner than at 1 month. A number of neovessels were
noted throughout the graft to the intima at 1 month. Less
were observed at 6 months in graft and perigraft adventitia,
and none were observed in the intima at 6 months. The
intima area at 6 months was significantly reduced compared
with 1 month (0.03 0.01 mm2 versus 0.11 0.09 mm2;
P  .05). The carotid artery lumen size at 6 months was
significantly reduced compared with 1 month (0.06 0.07
mm2 versus 0.10  0.03 mm2; P  .047).
-Actin and D33 desmin immunohistochemistry.
The native media (media opposite the graft side) of the
carotid arteries was positive for -actin and desmin, which
showed uniform immunoreactivity of vascular smooth
muscle cells at 1 month and 6 months. The native adven-
titia (adventitia opposite the graft side) was negative for
both -actin and desmin at 1 month and 6 months, as
opposed to smooth muscle cells.
The profiles of desmin staining were similar in perigraft
adventitia, graft matrix, and intima at both 1 month and 6
months. Perigraft adventitia and graft matrix were devoid
of desmin, and the intima had minimal desmin staining in
the anastomotic region where the intima was adjacent to
media. In this region, a small number of desmin-positive
cells were noted extending from the adjacent media (Fig 1).
At 1 month, a homogenous immunoreactivity with
-actin antibody extended from the perigraft adventitia
area through graft to the intima, whereas at 6 months, only
the intima and neovessels inside perigraft adventitia and
graft matrix retained immunoreactivity with -actin anti-
body (Fig 2). The perigraft adventitia, graft, and the ma-
jority of intima continued with -actin positive and nega-
tive for desmin at both 1 month and 6 months, except for
focal intimal area close to the anastomosis expressing both
-actin and D33 desmin (Fig 1). A few -actin–positive
cells were shown in intima adjacent to graft at 1 month but
were negative at 6 months. Furthermore, most -actin–
positive cells were absent in perigraft adventitia and graft
matrix at 6 months, and -actin expression in neovessels
was retained. At 6 months, -actin–positive cells appeared
only in neovessels at perigraft adventitia and graft matrix
(Fig 2). In intima, at 1 month, 80% to 90% of cells were
-actin immunoreactive compared with 98% at 6 months.
Less -actin–positive cells in the intima coincided with
accumulation of HAM 56–positive macrophages at 1
month.
Proliferation and phenotype. Native media and ad-
ventitia were negative for PCNA staining. No significant
difference was found in the number of proliferating cells
inside graft matrix and perigraft adventitia at 1 month and
6 months (9.16  3.59 versus 9.62  4.46; 4.58  4.12
versus 5.97  6.91; P  .56; P  .31, respectively). The
number of proliferating cells in the intima was significantly
higher at 1 month compared with 6 months (6.38  3.92
versus 1.71  2.72; P  .01).
The proliferating cells were located mainly around the
graft areas of intima, inside of the graft, and perigraft
adventitia at 1 month and 6 months. At 1 month and 6
months in perigraft regions, some of the proliferating cells
(PCNA positive) were also -actin positive. A similar colo-
calization pattern was observed in graft matrix at 1 month,
and less proliferating -actin–positive cells were noted at 6
months (Fig 3). At 1 month, most of the PCNA-positive
proliferating cells in the intima were -actin positive and a
small number were HAM 56 positive. At 6 months, only a
few PCNA-positive and -actin–positive cells were ob-
served and no proliferating HAM 56–positive cells were
detected in intima. Because of the complicated cell dedif-
ferentiation, some of the proliferating cell phenotypes were
not identified (Fig 3).
Apoptosis. In the intima at 1 month, significantly
more TUNEL-positive cells were seen than at 6 months
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(13.9, 125.0 versus 6.5, 65.0; P  .05). In contrast, in the
perigraft adventitia, significantly more TUNEL-positive
cells were seen at 6 months than at 1 month (12.5, 124.5
versus 7.3, 65.5; P .05). Inside the graft, a few TUNEL-
positive cells were seen for both time points. No apoptotic
cells were detected in the media and adventitia. In sum-
mary, at 1 month, numerous apoptotic cells were present in
the intima, whereas at 6 months, TUNEL-positive cells
were mainly present in perigraft adventitia (Fig 4). A few
apoptotic cells were -actin positive. However, most of the
cells were not identified.
Macrophage infiltration. In the graft matrix and
perigraft adventitia, the number of macrophages was not
significantly different at 1 month and 6 months (6.21 3.4
versus 4.20  1.1; P 	 .05). Many giant cells were seen
around the cross section of the graft. Inside the intima, the
number of macrophages per view at 1 month was signifi-
cantly greater than that at 6 months (10.8  9.7 versus
0.35  0.5; P  .05; Fig 3).
DISCUSSION
Infiltrating cell phenotypes. Knowledge of the phe-
notype of the proliferating cells is important because dis-
tinguishing cell phenotype is fundamental for development
of any pharmacologic intervention to prevent restenosis.
Our findings from this study suggest that perigraft adven-
titial -actin–positive cells but D33 desmin–negative cells
are likely to be the predominant infiltrating cells that con-
tribute to neointima formation, and these cells are not
smooth muscle cell origin. This is important to note be-
cause medial vascular smooth muscle cell (expressing both
-actin and D33 desmin) proliferation and migration to the
intima are known to be histologic features of restenosis in
human and experimental animal models.11,12 Cell prolifer-
ation is the key contributor to neointima formation and
arterial remodeling after arterial injury.4,13 Most proliferat-
ing cells in our study in perigraft adventitia, graft matrix,
and intima were -actin–positive and D33 desmin–nega-
tive cells. These proliferating cells may contribute to some
extent to neointima formation. The expansion of small
numbers of smooth muscle cells from adjacent media layer
was unlikely to contribute to the dense cell accumulation in
the perigraft adventitia, graft matrix, and intima. Convinc-
ing evidence exists to show that perigraft adventitial myo-
fibroblasts possess migratory ability and play a major part in
neointima formation in a vein bypass graft model.3 Because
the data from this study only included two isolated time
points, identification as to the origin of the cells cannot be
made and also the complexity of the infiltrating cell pheno-
typic change is indicated. The mechanisms involved with
cell infiltration are not clear. Some evidence exists to sup-
port a role of macrophages in the migration of myofibro-
Fig 1. Immunohistochemical staining profiles of -actin and desmin on sheep carotid artery cross sections after
Dacron patch implantation. Red staining identifies cells positive for -actin and desmin. A and B, At 1 month (n 9).
C and D, At 6 months (n 10). A and C, Native media (M) is reactive with both -actin and desmin, and few vessels
in native adventitia were also labeled. Perigraft adventitia (PG), graft matrix (G), and majority of intima (I) were
homogeneously reactive with -actin (A) but were negative for D33 desmin (C). Macroscopic magnification,10. B
and D, High-power photomicrographs of rectangular regions marked in A and C, respectively. At anastomotic areas
(AN), continuity of red staining was noted for -actin (B) and small number of red cells (curved arrow) stained for
desmin in adjacent intima (D). Microscopic magnification, 100. L, Lumen.
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blasts, pericytes, and smooth muscle cells towards the in-
tima. Macrophages secrete growth factors, such as basic
fibroblast growth factor, platelet-derived growth factor,
and transforming growth factor–
, and cytokines involved
in smooth muscle cell migration.14 Our data show that
inflammatory cell macrophages were mainly located in in-
tima and in graft matrix, with few in the perigraft adventitia.
A chemoattractant gradient forms as the result of distribu-
tion of macrophages and may direct those -actin–positive
and D33 desmin–negative cells and smooth muscle cell
migration.
No significant drop in proliferation was seen in peri-
graft and graft matrix regions at 6 months compared with 1
month, although overall proliferation was reduced as the
consequence of greatly reduced proliferative activity in the
intima. Another phenomena was observed with absence of
-actin–positive cells in the perigraft adventitia connective
tissue with thinning of adventitia at 6 months. This discrep-
ancy raises a question concerning the fate of proliferating
adventitial -actin–positive and D33 desmin–negative
cells.
Evidence of apoptosis. Apoptosis, which is different
from necrosis, has become an important feature in vascular
disease. An increased rate of smooth muscle cell and endo-
thelial cell turnover was noticed in a baboon carotid poly-
tetrafluoroethylene graft model.15 However, these early
studies do not give us direct evidence to show cellular
apoptosis in vascular graft implantation. Importantly, this
study is the first to show evidence of intimal cell apoptosis at
1 month and perigraft adventitia cell apoptosis at 6 months
after vascular patch implantation. Although the mecha-
nisms involved in the distribution of apoptotic cells are not
fully known, a role for macrophages has been suggested. In
rabbit iliac arterial stent implantation, macrophage accu-
mulation is the result of increased smooth muscle cell and
macrophage apoptosis.16 In our study, apoptotic cells were
mainly located in intima at 1 month and in perigraft adven-
titia at 6 months. Similarly, macrophages were mainly dis-
tributed in intima at 1 month and in perigraft adventitia at
6 months. Apoptotic cells and the apoptotic body are
engulfed by macrophages. Macrophages also secrete nu-
merous cytokines and growth factors, which may be related
to apoptotic activity. The relationship between macro-
phages and apoptosis is still not clear. Macrophage-derived
cytokines can induce upregulation of Fas (a type 1 mem-
brane protein transmitting apoptosis) in cultured vascular
smooth muscle cells.17 Fas-deficiency in mice also en-
hanced macrophage infiltration in flow-restricted vessels,
which suggested that Fas-mediated cell death could restrict
intimal hyperplasia in vascular remodeling.18
Fig 2. Photomicrographs show immunohistochemical labeling of -actin in sheep carotid arteries after Dacron patch
implantation. Positive cells stained red. More hematoxylin-labeled nuclei were noted in perigraft adventitia (PG) at 1
month (A and C; n  9) compared with 6 months (B and D; n  10). A and B, Red-positive cells suggested
-actin-positive cells spread through perigraft adventitia towards intima (I) at 1 month. Less neomicrovessels (arrow)
were observed in perigraft at 6 months (B). Microscopic magnification, 100. C and D, -Actin–positive cells
(open-end arrow and arrowhead) were scattered in perigraft adventitia at 1 month (C), and at 6 months, only neovessels
(arrowhead) were labeled with -actin (D). Endothelia nulei (small arrowhead) also were noted in inner side of
microvessels. Microscopic magnification, 250. L, Lumen.
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In addition, the proliferation status may contribute to
the distribution of apoptotic cells in intima and perigraft
adventitia. Our data show that the site of greatest apoptosis
was also the site of greatest proliferation. Similar findings
were also found in balloon injury models19,20 and in human
atherosclerotic specimens and restenosis lesions.5
Perigraft adventitia and intima remodeling. This
study did not define geometric arterial remodeling, but we
observed intima and perigraft adventitia remodeling after
vascular grafting. These remodeling processes featured as
morphometric and cellularity change in intima and peri-
graft adventitia similar to the tissue remodeling of wound
healing. The remodeling process occurred in two main
areas, the intima and the perigraft adventitia. Intima re-
modeling included reduced cell proliferating activity, in
which the intimal cells were quiescent at 6 months. The
prominent apoptotic activity at 1 month in the intima
might reduce the residual -actin–positive and D33
desmin–negative cell numbers in the intima. Certainly,
intima remodeling was not enough to explain the reduction
of intimal area because the source cells of intima were still
highly proliferating in graft matrix and perigraft adventitia
at 6 months, respectively. Among the three arterial layers,
the adventitia contains the largest amount of collagen, and
collagen plays an important role in arterial remodeling.21
Thus, the perigraft adventitia remodeling was crucial to the
process of arterial repair, in which perigraft adventitia cell
apoptosis was a main feature. Thereby, in the perigraft
adventitia, the continuing proliferating activity might be
balanced by the prominent apoptotic activity, leading to
reduction in source cells of intima. Thus, the source cell
number was reduced and cell migration was stopped before
reaching intima. In summary, intimal remodeling and peri-
graft adventitia remodeling together might account for the
benign effect of vascular remodeling after synthetic patch
grafting. Intimal cell apoptosis might account for the early
stage intimal cell accumulation, whereas perigraft adventi-
tial cell apoptosis might account for the late stage intimal
source cell reduction.
CONCLUSION AND FUTURE DIRECTION
Perigraft adventitia -actin–positive and D33 desmin–
negative cells might play an important role in neointima
formation. Cell proliferation and apoptosis might be im-
portant in perigraft adventitia and intima remodeling. Fur-
thermore, our investigation represents a static snapshot at
Fig 3. Photomicrographs show colocalization of PCNA and -actin on sheep carotid artery cross sections within graft
matrix (G) and intima (I) after Dacron patch implantation. A and C, At 1 month (n 9). B and D, At 6 months (n
10). A and B, In graft matrix (G), colocalization of PCNA and -actin was seen as cells stained with brown nuclei
surrounded with red cytoplasm. Proliferating -actin–positive cell in neovessels (arrowhead) and scattered proliferating
-actin–positive cells (open arrow) were noted at both 1 month and 6 months. More colocalization of PCNA and
-actin was shown at 1 month. Single PCNA labeling was noted at 1 month and 6 months. More neovessels (open
arrow) were shown at 1 month. Cross section of graft matrix was seen as white circle (arrow with curve end).
Magnification, 1000. C and D, In intima, colocalization of PCNA (arrow) and -actin. Significantly greater
colocalization of PCNA and -actin (arrowhead) seen in intima (I) at 1 month (C) compared with 6 months (D).
Magnification, 400. Counterstained with Mayer’s hematoxylin (blue colored nuclei). L, Lumen.
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two time points, and the complete kinetic picture of cell
phenotypic change needs to be further defined.
We thank Sulzer Vascutek Ltd, Glosgow, Scotland, for
supplying the synthetic vascular grafts.
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